Cargando…
Prognostic value of the DNA integrity index in patients with malignant lung tumors
INTRODUCTION: Lung cancer survival remains poor in the western world due to late presentation in most cases, leading to difficulty of treatment in these advanced and metastatic patients. Therefore, the development of a robust biomarker for prognosis and to monitor treatment response and relapse woul...
Autores principales: | Chudasama, Dimple Y., Aladag, Zeynep, Felicien, Mayla I., Hall, Marcia, Beeson, Julie, Asadi, Nizar, Gidron, Yori, Karteris, Emmanouil, Anikin, Vladimir B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940399/ https://www.ncbi.nlm.nih.gov/pubmed/29765538 http://dx.doi.org/10.18632/oncotarget.25086 |
Ejemplares similares
-
Perioperative detection of circulating tumour cells in patients with lung cancer
por: Chudasama, Dimple, et al.
Publicado: (2017) -
Lack of association between Screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical study
por: Barr, James, et al.
Publicado: (2020) -
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers
por: Chudasama, Dimple, et al.
Publicado: (2018) -
Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery
por: Katopodis, Periklis, et al.
Publicado: (2021) -
Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer
por: Kumar, Juhi, et al.
Publicado: (2019)